Mitochondrial transfer as a novel therapeutic approach in disease diagnosis and treatment
VJ Clemente-Suárez, A Martín-Rodríguez… - International Journal of …, 2023 - mdpi.com
Mitochondrial dysfunction is a hallmark of numerous diseases, including neurodegenerative
disorders, metabolic disorders, and cancer. Mitochondrial transfer, the transfer of …
disorders, metabolic disorders, and cancer. Mitochondrial transfer, the transfer of …
Redefining autoimmune disorders' pathoetiology: implications for mood and psychotic disorders' association with neurodegenerative and classical autoimmune …
Although previously restricted to a limited number of medical conditions, there is a growing
appreciation that 'autoimmune'(or immune-mediated) processes are important aspects of a …
appreciation that 'autoimmune'(or immune-mediated) processes are important aspects of a …
Mitochondria-targeted delivery strategy of dual-loaded liposomes for Alzheimer's disease therapy
L Vasileva, G Gaynanova, F Valeeva… - International Journal of …, 2023 - mdpi.com
Liposomes modified with tetradecyltriphenylphosphonium bromide with dual loading of α-
tocopherol and donepezil hydrochloride were successfully designed for intranasal …
tocopherol and donepezil hydrochloride were successfully designed for intranasal …
Mitochondria and brain disease: a comprehensive review of pathological mechanisms and therapeutic opportunities
VJ Clemente-Suárez, L Redondo-Flórez… - Biomedicines, 2023 - mdpi.com
Mitochondria play a vital role in maintaining cellular energy homeostasis, regulating
apoptosis, and controlling redox signaling. Dysfunction of mitochondria has been implicated …
apoptosis, and controlling redox signaling. Dysfunction of mitochondria has been implicated …
Mitochondrial Dysfunction as the Major Basis of Brain Aging
SC Bondy - Biomolecules, 2024 - mdpi.com
The changes in the properties of three biological events that occur with cerebral aging are
discussed. These adverse changes already begin to develop early in mid-life and gradually …
discussed. These adverse changes already begin to develop early in mid-life and gradually …
Targeting VDAC: A potential therapeutic approach for mitochondrial dysfunction in Alzheimer's disease
Y Yang, X Jia, X Yang, J Wang, Y Fang, X Ying… - Brain Research, 2024 - Elsevier
Mitochondrial dysfunction has been implicated in the pathogenesis of Alzheimer's disease, a
neurodegenerative disorder characterized by progressive cognitive decline. Voltage …
neurodegenerative disorder characterized by progressive cognitive decline. Voltage …
Review of Pharmacotherapeutic Targets in Alzheimer's Disease and Its Management Using Traditional Medicinal Plants
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by
cognitive decline, memory loss, and impaired daily functioning. While there is currently no …
cognitive decline, memory loss, and impaired daily functioning. While there is currently no …
Oleoylethanolamide improves energy disposal in a cellular model of Alzheimer's disease
A Quentin, F Dieter, M Reutzel… - Journal of Mitochondria …, 2024 - Taylor & Francis
Oleoylethanolamide (OEA) is an endogenous lipid mediator which is being discussed as a
weight-loss drug for obesity. In addition to its homoeostatic functions, OEA has …
weight-loss drug for obesity. In addition to its homoeostatic functions, OEA has …
The long term effects of uncoupling interventions as a therapy for dementia in humans
AG Holt, AM Davies - Journal of Theoretical Biology, 2024 - Elsevier
In this paper we use simulation methods to study a hypothetical uncoupling agent as a
therapy for dementia. We simulate the proliferation of mitochondrial deletion mutants …
therapy for dementia. We simulate the proliferation of mitochondrial deletion mutants …
The Mitochondrion as the Major Basis of Brain Aging
SC Bondy - 2024 - preprints.org
The changes in the properties of three biological events, that occur with cerebral aging, are
discussed. These adverse changes already begin to develop early in mid-life and gradually …
discussed. These adverse changes already begin to develop early in mid-life and gradually …